---
title: "Issue #2: Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation"
date: 2025-12-21
description: "Protein Design Digest - 2025-12-21 - Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation"
author: "Protein Design Digest"
tags: ["bioinformatics", "newsletter", "research"]
---

{{< newsletter >}}

## ðŸš€ Today's Top Signal

### [Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation](https://doi.org/10.21203/rs.3.rs-8186049/v1)
_Enhances small-molecule or peptide docking accuracy for targeted drug discovery._

Abstract As a traditional hair-growth-promoting herb, Platycladi Cacumen(PC) has a long history of folk application in the field of hair loss improvement. Preliminary modern pharmacological studies have suggested that its active components may exert potential effects by regulating hair follicle-related signaling pathways; however, for androgenetic alopecia (AGA), the exact targets and specific regulatory mechanisms of PC remain unelucidated, which provides a direction for research on natural drug-based intervention in AGA. In this study, network pharmacology was employed to predict the active components and core targets of PC. Targets associated with AGA were collected, and the intersection targets between PC and AGA were identified. Subsequently, protein-protein interaction (PPI) analysis, Gene Ontology (GO) enrichment analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed on the intersection targets to screen out the core targets. Thereafter, molecular docking and molecular dynamics simulation were conducted to validate the interactions between key active components and core targets. The component-target network diagram included 1044 interaction relationships between 32 components and 439 targets, among which quercetin, apigenin, myricetin, and hinokinin were identified as key components. The disease-target network diagram summarized 410 targets associated with AGA. Through PPI network analysis, key targets such as ESR1, BCL2, INS, AR, and STAT3 were screened out. The results of GO enrichment analysis and KEGG pathway analysis revealed that PC may exert its effects by regulating the EGFR receptor molecule and pathways including the HIF-1 signaling pathway. Molecular docking results showed that the binding energies of all complexes were less than -6.4 kcal/mol, indicating favorable binding effects. Molecular dynamics simulation results showed that the root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), radius of gyration (Rg), solvent-accessible surface area (SASA), two-dimensional free energy landscape (FEL-2D), and FEL-3D of the simulation system all remained in an equilibrium state with small fluctuation amplitudes. This result indicated that the molecular system had a stable overall conformation, restricted local residue movement, a compact spatial structure, and stable internal chemical bondsâ€”collectively confirming that the quercetin-STAT3, apigenin-AR, myricetin-STAT3, and hinokinin-AR complexes exhibited extremely strong binding stability. Collectively, Overall, this study systematically investigated the mechanism of action and potential value of PC leaves in intervening in AGA, providing a solid theoretical basis for the intervention of AGA with PC.

---

## âš¡ Quick Reads

### [From sweetener to risk factor: Network toxicology, molecular docking and molecular dynamics reveal the mechanism of aspartame in promoting coronary heart disease.](https://doi.org/10.1016/j.cbi.2025.111876)
Aspartame, a widely used non-nutritive sweetener, has been epidemiologically linked to coronary heart disease (CHD), although the underlying mechanisms remain unclear. This study employed an integrative computational strategy combining network toxicology, molecular docking, and molecular dynamics to decode aspartame's CHD-promoting mechanisms. Initially, the toxicity profile of aspartame was predicted using ProTox 3.0 and ADMETlab 3.0, which highlighted significant cardiotoxicity. Through multi-source target screening of aspartame (PharmMapper, SEA, etc.) and CHD (GeneCards, OMIM), 216 shared targets were identified. Protein-protein interaction network analysis revealed 10 hub targets (INS, PPARGC1A, TNF, AKT1, IL6, MMP9, IGF1, PTGS2, SIRT1, PPARG). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses revealed significant enrichment in lipid metabolism, inflammatory responses, insulin resistance, and atherosclerosis-related pathways. Molecular docking and molecular dynamics simulations (MDS) demonstrated high-affinity binding of aspartame to three core targets (PTGS2, TNF, and PPARGC1A), with a binding energy â‰¤ -7.0 kcal/mol, and confirmed high binding stability. This study reveals that aspartame may promote the pathogenesis of CHD by disrupting cardiovascular homeostasis through multi-target interactions, including inflammatory response, metabolic dysregulation, and vascular remodeling. These findings provide molecular evidence for re-evaluating the safety profile of aspartame and establish a computational framework to guide experimental validation and preventive strategies.

### [Computational insights into Ru(II)-coumarin complexes as potential anticancer agents: a DFT, QTAIM, NCI-RDG, molecular docking and molecular dynamics approach.](https://doi.org/10.1039/d5cp03171k)
Ru(II) complexes have been explored as promising candidates for novel anticancer agents, due to their significant bioactivity, selective cytotoxicity, and ability to induce apoptosis via multiple signalling pathways, with coumarin derivatives serving as effective ligands to enhance their therapeutic efficacy. DFT calculations are highly useful in comprehensively analyzing the electronic structures, and physicochemical and thermodynamic properties of these metal complexes. For example, MEP maps are used to visualize the molecular charge distribution, while NBO analysis is employed to investigate the charge transfer interactions. The donor-acceptor behaviour of the metal-ligand complexes is also examined to gain deeper insights into their electronic properties and potential reactivity. QTAIM analysis confirms that weak H-bonding and vdW interactions significantly stabilize the studied adducts, particularly [RuCl 2 (yc4) 2 (DMSO) 2 ]Â·2H 2 O and AT/GC base pair complexes. Molecular docking is further employed to investigate the DNA-binding affinity and interaction mechanisms of these complexes, with a specific focus on AT/GC nucleobases. The molecular docking results provide insights into the stability of the adducts and reveal their preferred binding sites within DNA nucleobases. Finally, molecular dynamics simulation calculations were employed to complement DFT and docking analyses. Again, MM/PBSA free energy and H-bond analyses indicate stronger thermodynamic interactions of the [RuCl 2 (yc4) 2 (DMSO) 2 ]Â·2H 2 O complex with AT-rich regions. Hence, this in silico study on Ru(II)-coumarin complexes offers valuable insights for the rational design of metal-based anticancer therapeutics.

### [Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukemia treatment: Molecular docking and molecular dynamics simulation approaches.](https://doi.org/10.1016/j.bbrc.2025.153115)
Myeloid cell leukemia-1 (Mcl-1), an anti-apoptotic member of the Bcl-2 family, is frequently overexpressed and amplified in chronic myeloid leukemia (CML) as well as in several other malignancies, contributing to tumor progression and therapeutic resistance. The present study employed a multi-step virtual screening approach to identify potential inhibitors of the Mcl-1 protein and subsequently validated their inhibitory activity through computational approaches. The 3-D structure of Mcl-1 protein was retrieved from the protein data bank and subjected to structure-based virtual screening. A series of drug-likeness and ADMET filters, including Lipinski filter, Swiss ADME, ADME-Tox, pKCSM and Protox-3 web, were applied to prioritize the compounds with favorable pharmacokinetic and toxicity profile. Further evaluated by molecular docking, with particular emphasis on -CDOCKER interaction energy, identified tolbutamide (-101.09 kcal/mol), leucodelphinidin (-89.304 kcal/mol), and gossypetin -70.49 (kcal/mol) as, most promising candidates. To assess the conformational stability and dynamic behavior of the protein-ligand complexes, molecular dynamics simulation was performed for 100ns and extended to 500 ns for the best screened compound. Trajectory analysis was conducted using multiple descriptors, including root mean square deviation, root mean square fluctuation, the radius of gyration, solvent-accessible surface area (SASA), hydrogen bonds, and free energy landscape. In vitro toxicity studies using the MTT assay on the K562 chronic myeloid leukemia cell line demonstrated a significant reduction in cell viability, indicating potent antiproliferative activity. These computational studies highlight novel compounds as potent Mcl-1 inhibitors, suggesting their potential as promising therapeutic candidates for the treatment of CML. These findings lay the foundation for further optimization and preclinical evaluation of Mcl-1 targeted compounds in cancer therapy.

## ðŸ¤– AI in Bio
- **[Building the Next Generation of Biologics: Inside the Future of Protein Engineering - BioSpace](https://news.google.com/rss/articles/CBMiwgFBVV95cUxPX29zZlZ1dVFzRmdCbXZ4OHJfM3dxZEFiMmM0X2t3Y1lTdHhVNW4yb016dHc1ZnFhMnNPVGZtNkh1d3E0NkRYUjVqMFdnQlA3ZlFKOHVoVnlERzg3OWJlRVJDVjRYeW5yUWFybVg4TUd3dnBpNlRYRUdiMlpGUmh4REx5RXBFSVNadFM0MV9NOHROUEV6dGRSSmg1bENPZFFHa0lEUHR4M2toM3ZaZVVLUFdIMWI0YVZTOVVNR2JOZzN3QQ?oc=5)**: Building the Next Generation of Biologics: Inside the Future of Protein Engineering &nbsp;&nbsp; BioSpace
- **[Turning AI into a biological design engine - Drug Target Review](https://news.google.com/rss/articles/CBMikgFBVV95cUxOWWZmeGlfRlBzQVJJTUN4T3ZhWTMtNGs4MF92Zy1hVFhwcnNqLVNtemt6eFdVeVFGOWMtZkZNN0pHZzBXY3dMMlljVm9vNExIcXBjN1Z2MnlPNHVBcm1KcTBoZnFCTWdCTjlFczJyVnlvUi1xSTJJekw4MHo2d0lMUWlSTjJhbVdlSktMZEh3UjZqZw?oc=5)**: Turning AI into a biological design engine &nbsp;&nbsp; Drug Target Review
- **[Folding the Future: How AI is Reshaping Protein Engineering - SynBioBeta](https://news.google.com/rss/articles/CBMilAFBVV95cUxQcUhMVFhUMDJxdDZXeHQ5ejNJa2VSbUJQbDV0YTNmb05LbnZ1RUt6cTJBS2tLMkVDTEpndTVONmVCUExSeExGWWtseHZndlVTUXBHSy1TYkVHTFdSZjNBNUtIQ1BWTV9aeDluSEo3MWJJU29XS3JHd1E0eFlZSEh6cDNPVklONzVPTVRHWHVOaXY1LUdR?oc=5)**: Folding the Future: How AI is Reshaping Protein Engineering &nbsp;&nbsp; SynBioBeta

## ðŸ’¡ Pipeline Tip
Index your BigWig files before visualization to save memory.

---
## ðŸ› ï¸ Resources
- **Dataset**: [BINDER](http://www.binder-db.org/) - A curated database for protein-protein binding affinity and structures.
- **Tool**: [ChimeraX](https://www.rbvi.ucsf.edu/chimerax/) - Next-gen molecular visualization for large data sets.
- **Event**: [Protein Design Hub (LinkedIn)](https://www.linkedin.com/groups/13501256/) (Ongoing)
- **Job**: [Search LinkedIn](https://www.linkedin.com/jobs/search/?keywords=protein%20design%20bioinformatics) at LinkedIn Jobs

> *The protein structure is the language of life; design is its poetry.* â€” Recep Adiyaman
